← Open Payments lookup

JENNIFER LANG: Open Payments

NPI 1003364795 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,928 in 82 payments from 17 companies in 2025. Trend: 2023 $1,287 · 2024 $1,764 · 2025 $1,928

Food & beverage: $1,928
CompanyPaymentsAmount
ABBVIE INC.22$496
Janssen Biotech, Inc.7$166
GENZYME CORPORATION6$160
PFIZER INC.9$157
Takeda Pharmaceuticals U.S.A., Inc.8$147
Ardelyx, Inc.3$142
Janssen Scientific Affairs, LLC1$127
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$107
Phathom Pharmaceuticals, Inc.7$95
Ipsen Biopharmaceuticals, Inc4$91

Products named: RINVOQ, TREMFYA, ENTYVIO, IBSRELA, XELJANZ, XIFAXAN, VOQUEZNA, IQIRVO.

Industry payments across MD — which companies pay providers there.